Hemodiyaliz Hastalarında HBV, HCV ve HIV Seroprevalansı ve Hepatit B Aşılaması ile Oluşan Antikor Cevabının Değerlendirilmesi

Temiz, Hakan; Kaya, Şafak; Berekatoğlu, Nuh; Temiz, Sevim; Danış, Ramazan

doi:10.4274/vhd.66375

Cited by 3 publications

(4 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies conducted in our country have shown that hemodialysis patients have anti-HCV positivity at rates ranging from 1.2% to 16% (2,4,(14)(15)(16)(17)(18)(19). Among international studies, the prevalence of anti-HCV was determined as 4.3% by The rate of anti-HIV positivity in our dialysis centeris higher than those reported in other Turkish studies.…”

Section: Discussionmentioning

confidence: 52%

Overview of blood-borne viral infections in hemodialysis patients: hepatitis B, hepatitis C, human immunodeficiency virus infections

Aydın

Ergen

Erbakan

et al. 2022

Journal of Health Sciences and Medicine

View full text Add to dashboard Cite

Aim: This study aimed to examine the blood-borne viral infections such as hepatitis B, hepatitis C and human immunodeficiency virus (HIV) and to determine the risk factors in hemodialysis patients. Material and Method:The datas of patients who underwent hemodialysis in the hemodialysis unit of our hospital between March 1, 2020 and March 1, 2021 were reviewed retrospectively. Their sociodemographic characteristics, habits, underlying diseases and virological indicators related to hepatitis B, hepatitis C and HIV were obtained from patient files and hospital data processing system.Results:A total of 96 patients were included in the study. Of them, 43.8% (n=42) were female and 56.2% (n=54) were male. Their mean age was 62.61±18.11 years, ranging from 17 to 92. The duration of dialysis was less than 3 months for 46.9% (n=45) of the patients, between 3 months and 3 years for 19.8% (n=19), and 3 years and above for 33.3% (n=32). Thirty patients (31.3%) had diabetes mellitus. In addition, 1% (n=1) of the patients had HBsAg positivity, 3.1% (n=3) had anti-HCV positivity, 59.4% (n=57) had Anti-HBs positivity and 2.1% (n=2) had anti-HIV positivity. No statistically significant difference was found between the patients' HBsAg, anti-HCV and anti-HIV positivity according to gender, duration of dialysis, dialysis application site, alcohol use, surgical intervention and blood transfusion history (p>0.05). Conclusion:Hemodialysis patients may be at risk for hepatitis B, hepatitis C and HIV infection if infection control guidelines are not followed strictly. In addition to complying with these guidelines, both health workers and patients should be trained constantly, patients' virological indicators should be tested regularly and hepatitis B vaccine should be administered to hemodialysis patients without seroconversion.

show abstract

Section: Discussionmentioning

confidence: 52%

Overview of blood-borne viral infections in hemodialysis patients: hepatitis B, hepatitis C, human immunodeficiency virus infections

Aydın

Ergen

Erbakan

et al. 2022

Journal of Health Sciences and Medicine

View full text Add to dashboard Cite

show abstract

“…Accordingly, while mild stimuli create satisfaction and pleasure, stronger stimuli create a penalty effect. Thus, using a very intensive stimulation for rewarding, we cause to unfavorable effect so, desired behavior becomes a behavior to be avoided (5).…”

Section: Evaluation Of Methods Used and Conclusion With Regard To Ethical-social-legal Aspectsmentioning

confidence: 99%

“…Since the etiology of violence depends on one's experience and his/her genes, the treatment methods should start with changing these experiences and changing the genetic activity by epigenetic acquisition. If environmental impulses could change one's brain by means of neural plasticity forcing to learn the good skills, and forcing to be a good person, we could have decreased the violence in the next generations (5). May be the violence in that community could be erased and from the brains.…”

Section: Memory Neurochemistry and 'Immediate Early Genes'mentioning

confidence: 99%

“…In the scientific experiments, it is proven that there was a decrease in learning and destruction in memory due to high level of stress. In another experiment, when ventromedial nucleus known as rewarding center was electrically stimulated, the animals continue to push the stimulating lever(4).Thus, stimulation of the rewarding center had motivated the animal's behavior (5).The result here the hypothesis of motivation and rewarding to the animals or human beings is an effector factor to teach them good behaviors and values.…”

Section: Memory Neurochemistry and 'Immediate Early Genes'mentioning

confidence: 99%

See 1 more Smart Citation

Suppressing the Violence in the Brain by Neuroplasticity; Is it ethical?

Daşdemir

Pınar

Çobanoğlu

2018

GMJ

View full text Add to dashboard Cite

The phenomenon of violence which has been seen in all historical ages is a behavioral pathology and has increased in various communities and time and has never been exactly handled. Communities usually deal with the results instead of investigating the reasons of the violence and often tend towards to the treatment solutions with palliative methods, and try to suppress and prevent violence through various laws and criminal procedures. However, instead of focusing on the palliative methods, reasons of violence need to be investigated with scientific studies and new treatment methodologies need to be developed. This project has been suggested by a student who is a medical doctor candidate in order to contribute to the solution of the violence issue. The mechanisms of "neural plasticity depending on learning" forms the basis of this hypothesis Therefore, the possibility of creating cognitive and behavioral changes in humans with the learning methods that may lead to neuroplasticity, has been reviewed in the related literature. Additionally, the efficiency of this type of learning methods in preventing the violence and the ethical issues were discussed.

show abstract

Investigation of the change in seroprevalence of viral hepatitis in patients receiving hemodialysis treatment over the years: A Single-Center Study

KOÇULU DEMİR,

AKAGÜN

2023

Experimental and Applied Medical Science

View full text Add to dashboard Cite

Objective: In this study, it was aimed to evaluate HBV, HCV, and HIV seroprevalence and their 9-year changes in patients receiving hemodialysis (HD) treatment in the Giresun province in Turkey. Material-Methods: A total of 607 patients over the age of 18 who received hemodialysis treatment in Giresun – Turkey, provincial and district hospitals in 2013 and 2022 were included in our study. The files of the patients were reviewed retrospectively. Demographic characteristics of the patients and serology results of HBV, HCV, HDV, and HIV were recorded. The data was evaluated using the IBM SPSS Statistics 25.0 program. Results: A total of 607 patients, 385 of whom received HD treatment in 2013 and 222 who received HD treatment in 2022, were included in the study. 230 (59.7%) in 2013 and 135 (60.8%) in 2022 of male patients. While the mean age of the patients was 60.26±14 years in 2013, it was 63.08±13.18 years in 2022. In 2013, HBsAg positivity was detected in 9 (2.3%), HBV-DNA positivity in 4 (44.4%), anti-HCV positivity in 31 (8.1%), and HCV-RNA positivity in 8 (25.8%) patients. In 2022, HBsAg positivity was detected in 4 (1.8%), HBV DNA positivity in 2 (50%), and anti-HCV positivity in 31 (8.1%) patients. Compared with dialysis duration, the anti-HCV positivity rate was significantly increased in patients with long dialysis duration (p

show abstract

Hemodiyaliz Hastalarında HBV, HCV ve HIV Seroprevalansı ve Hepatit B Aşılaması ile Oluşan Antikor Cevabının Değerlendirilmesi

Cited by 3 publications

References 14 publications

Overview of blood-borne viral infections in hemodialysis patients: hepatitis B, hepatitis C, human immunodeficiency virus infections

Overview of blood-borne viral infections in hemodialysis patients: hepatitis B, hepatitis C, human immunodeficiency virus infections

Suppressing the Violence in the Brain by Neuroplasticity; Is it ethical?

Investigation of the change in seroprevalence of viral hepatitis in patients receiving hemodialysis treatment over the years: A Single-Center Study

Contact Info

Product

Resources

About